SCHEMBL8438702

SCHEMBL8438702

COCCOc1c(C#N)ccc(N2CCNCC2)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 1/20 0.42
ALDH1A1 P00352 1/20 0.41
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
ROCK2 O75116 1/20 0.39
ROCK1 Q13464 1/20 0.39
CDC42BPB Q9Y5S2 1/20 0.39
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTR6 P50406 2/20 0.36
HTR3E A5X5Y0 2/20 0.36
HTR3B O95264 2/20 0.36
HTR3A P46098 2/20 0.36
HTR3D Q70Z44 2/20 0.36
HTR3C Q8WXA8 2/20 0.36
CFD P00746 1/20 0.35
ADRB1 P08588 1/20 0.35
DRD2 P14416 1/20 0.35
CYP2C19 P33261 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8431915 0.85 ALDH1A1 (0.47) ALDH1A1ROCK2ROCK1CDC42BPBLMNA
SCHEMBL14922251 0.79 RET (0.51) RETALDH1A1CHRNB2CHRNA4ROCK2
Hydrochloric Acid SCHEMBL23855496 0.79 LMNA (0.44) CHRNB2CHRNA4LMNAMAPTHTR6
SCHEMBL8431903 0.79 ALDH1A1 (0.56) RETALDH1A1CHRNB2CHRNA4ROCK2
SCHEMBL21659247 0.77 HTR1A (0.44) CHRNB2CHRNA4LMNAMAPTHTR6
SCHEMBL8295772 0.76 ALDH1A1 (0.54) ALDH1A1ROCK2ROCK1CDC42BPBLMNA
SCHEMBL8436191 0.74 AR (0.40)
SCHEMBL14922738 0.73 CHRNB2 (0.48) RETCHRNB2CHRNA4HTR3EHTR3B
SCHEMBL8436383 0.73 CHRNB2 (0.48) RETCHRNB2CHRNA4HTR3EHTR3B
Hydrochloric Acid SCHEMBL23855500 0.73 CHRNB2 (0.50) CHRNB2CHRNA4LMNAMAPTHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368449-B2 2-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists SCHERING CORPORATION (US) 2008-05-06 US disclosed
US-20040220194-A1 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists SCHERING CORPORATION 2004-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220194-A1 2-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists ADORA2A, ADORA3, ADORA1 RET 624/4885ALDH1A1 591/4885CHRNB2 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.